136 related articles for article (PubMed ID: 34253698)
1. Systemic Fibrocyte Levels and Keloid Expression of the Chemoattractant CXCL12 Are Upregulated Compared With Patients With Normal Scar.
Campbell CA; Burdick MD; Strieter RM
Ann Plast Surg; 2021 Aug; 87(2):150-155. PubMed ID: 34253698
[TBL] [Abstract][Full Text] [Related]
2. Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring.
Iqbal SA; Sidgwick GP; Bayat A
Arch Dermatol Res; 2012 Oct; 304(8):665-71. PubMed ID: 22407077
[TBL] [Abstract][Full Text] [Related]
3. TSLP Is a Potential Initiator of Collagen Synthesis and an Activator of CXCR4/SDF-1 Axis in Keloid Pathogenesis.
Shin JU; Kim SH; Kim H; Noh JY; Jin S; Park CO; Lee WJ; Lee DW; Lee JH; Lee KH
J Invest Dermatol; 2016 Feb; 136(2):507-515. PubMed ID: 26824743
[TBL] [Abstract][Full Text] [Related]
4. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
[TBL] [Abstract][Full Text] [Related]
5. Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis.
Nicastro M; Vescovini R; Maritati F; Palmisano A; Urban ML; Incerti M; Fenaroli P; Peyronel F; Benigno GD; Mangieri D; Volpi R; Becchi G; Romagnani P; Corradi D; Vaglio A
Arthritis Rheumatol; 2019 Nov; 71(11):1913-1922. PubMed ID: 31233292
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model.
Harris DA; Zhao Y; LaPar DJ; Emaminia A; Steidle JF; Stoler M; Linden J; Kron IL; Lau CL
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):854-61. PubMed ID: 22626514
[TBL] [Abstract][Full Text] [Related]
7. Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway.
Dupin I; Allard B; Ozier A; Maurat E; Ousova O; Delbrel E; Trian T; Bui HN; Dromer C; Guisset O; Blanchard E; Hilbert G; Vargas F; Thumerel M; Marthan R; Girodet PO; Berger P
J Allergy Clin Immunol; 2016 Apr; 137(4):1036-1042.e7. PubMed ID: 26602164
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway.
Smadja DM; Dorfmüller P; Guerin CL; Bieche I; Badoual C; Boscolo E; Kambouchner M; Cazes A; Mercier O; Humbert M; Gaussem P; Bischoff J; Israël-Biet D
Thromb Haemost; 2014 Nov; 112(5):1002-13. PubMed ID: 25103869
[TBL] [Abstract][Full Text] [Related]
9. Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation.
Liu Y; Niu XH; Yin X; Liu YJ; Han C; Yang J; Huang X; Yu X; Gao L; Yang YZ; Xia YL; Li HH
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535140
[TBL] [Abstract][Full Text] [Related]
10. Fibrocyte trafficking in patients with chronic obstructive asthma and during an acute asthma exacerbation.
Wang CH; Punde TH; Huang CD; Chou PC; Huang TT; Wu WH; Liu CH; Chung KF; Kuo HP
J Allergy Clin Immunol; 2015 May; 135(5):1154-62.e1-5. PubMed ID: 25441632
[TBL] [Abstract][Full Text] [Related]
11. Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia.
Li C; Li X; Deng C; Guo C
PLoS One; 2016; 11(6):e0157181. PubMed ID: 27309347
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of DPP4-CXCL12 Balance by TGF-β1/SMAD Pathway Promotes CXCR4
Chen Z; Gao Z; Xia L; Wang X; Lu L; Wu X
J Inflamm Res; 2021; 14():4169-4180. PubMed ID: 34483675
[TBL] [Abstract][Full Text] [Related]
13. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
Phillips RJ; Burdick MD; Hong K; Lutz MA; Murray LA; Xue YY; Belperio JA; Keane MP; Strieter RM
J Clin Invest; 2004 Aug; 114(3):438-46. PubMed ID: 15286810
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
15. Another Piece in the Fibrotic Puzzle: TSLP as a Novel Ligand for Fibrocyte Activation.
Christmann RB
J Invest Dermatol; 2016 Feb; 136(2):360-362. PubMed ID: 26802232
[TBL] [Abstract][Full Text] [Related]
16. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.
Mehrad B; Burdick MD; Strieter RM
Int J Biochem Cell Biol; 2009; 41(8-9):1708-18. PubMed ID: 19433312
[TBL] [Abstract][Full Text] [Related]
17. Circulating fibrocytes--biology and mechanisms in wound healing and scar formation.
Grieb G; Steffens G; Pallua N; Bernhagen J; Bucala R
Int Rev Cell Mol Biol; 2011; 291():1-19. PubMed ID: 22017972
[TBL] [Abstract][Full Text] [Related]
18. p53 and apoptosis alterations in keloids and keloid fibroblasts.
Ladin DA; Hou Z; Patel D; McPhail M; Olson JC; Saed GM; Fivenson DP
Wound Repair Regen; 1998; 6(1):28-37. PubMed ID: 9776848
[TBL] [Abstract][Full Text] [Related]
19. The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.
Strieter RM; Keeley EC; Burdick MD; Mehrad B
Trans Am Clin Climatol Assoc; 2009; 120():49-59. PubMed ID: 19768162
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
